MARKET

PAVM

PAVM

Pavmed
NASDAQ
4.210
-0.500
-10.62%
Pre Market: 4.560 +0.35 +8.31% 08:05 08/13 EDT
OPEN
4.680
PREV CLOSE
4.710
HIGH
4.680
LOW
4.190
VOLUME
697
TURNOVER
0
52 WEEK HIGH
28.44
52 WEEK LOW
3.850
MARKET CAP
30.62M
P/E (TTM)
-0.1127
1D
5D
1M
3M
1Y
5Y
1D
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
PR Newswire · 43m ago
*Lucid Diagnostics 2Q Rev $1.5M >LUCD
Dow Jones · 43m ago
Press Release: Lucid Diagnostics Provides -2-
Dow Jones · 43m ago
Weekly Report: what happened at PAVM last week (0803-0807)?
Weekly Report · 3d ago
Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more
Seeking Alpha · 4d ago
Lucid announces Concert issued positive coverage policy for EsoGuard test
TipRanks · 08/05 14:06
Weekly Report: what happened at PAVM last week (0727-0731)?
Weekly Report · 08/03 09:49
Weekly Report: what happened at PAVM last week (0720-0724)?
Weekly Report · 07/27 09:51
More
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.

Webull offers PAVmed Inc stock information, including NASDAQ: PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.